Acoustic Medsystems

Acoustic Medsystems

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30M

Overview

Acoustic MedSystems is pioneering focused ultrasound technology for non-invasive therapeutic applications, primarily targeting soft tissue conditions and pain. Founded in 2009 and based in Champaign, Illinois, the company leverages image-guidance to deliver precise acoustic energy, aiming to offer alternatives to surgery or pharmaceutical interventions. As a private entity, it is likely in a development or early clinical stage, positioning itself in the growing market for minimally invasive treatments. Its success hinges on clinical validation, regulatory clearance, and eventual commercialization of its platform.

CardiovascularPain ManagementOncology

Technology Platform

Image-guided, minimally and non-invasive focused ultrasound platform for targeted soft tissue therapy and ablation.

Funding History

2
Total raised:$30M
Series B$20M
Series A$10M

Opportunities

The growing demand for outpatient, non-invasive surgical alternatives across cardiology, oncology, and pain management represents a massive market opportunity.
The platform's potential applicability to multiple high-value indications allows for a diversified product strategy and multiple value inflection points.
Favorable healthcare trends toward value-based care and reduced opioid use support the adoption of device-based, minimally invasive therapies.

Risk Factors

The company faces significant technical and clinical risk in proving safety and efficacy in human trials, as well as substantial regulatory risk in navigating the FDA clearance process.
It operates in a highly competitive landscape against large, well-capitalized medical device corporations and other startups.
As a pre-revenue private company, it is dependent on securing ongoing funding, which is contingent on achieving high-risk development milestones.

Competitive Landscape

Acoustic MedSystems competes in the focused ultrasound therapeutic space against public companies like Insightec (MRI-guided FUS) and Profound Medical (MRI-guided TULSA), as well as divisions of large device makers (e.g., Philips, Siemens Healthineers). In specific applications like cardiac ablation, it faces entrenched competition from electrophysiology giants such as Medtronic, Johnson & Johnson (Biosense Webster), and Boston Scientific. Its differentiation hinges on the specifics of its image-guidance approach, transducer design, and procedural workflow.